First Trust NYSE Arca Biotechnology ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FBT and other ETFs, options, and stocks.

About FBT

FBT tracks an equal-weighted index of US biotechnology stocks. The listed name for FBT is First Trust NYSE Arca Biotechnology Index Fund. 

Index-Tracked
S&P 500 TR USD
Index-TrackedS&P 500 TR USD
Category
Health
CategoryHealth
Number of holdings
33
Number of holdings33
Inception Date
Jun 19, 2006
Inception DateJun 19, 2006

FBT Key Statistics

AUM
2.34B
AUM2.34B
Price-Earnings ratio
52.35
Price-Earnings ratio52.35
30-Day yield
30-Day yield
Average volume
53.80K
Average volume53.80K
High today
$209.38
High today$209.38
Low today
$207.24
Low today$207.24
Open price
$208.97
Open price$208.97
Volume
33.00K
Volume33.00K
52 Week high
$224.94
52 Week high$224.94
52 Week low
$152.78
52 Week low$152.78
Expense ratio
0.55
Expense ratio0.55

Stock Snapshot

With a market cap of 2.35B, First Trust NYSE Arca Biotechnology ETF(FBT) trades at $208.48. The stock has a price-to-earnings ratio of 52.35 and currently yields dividends of 21.5%.

As of 2026-05-05, First Trust NYSE Arca Biotechnology ETF(FBT) stock has fluctuated between $207.24 and $209.38. The current price stands at $208.48, placing the stock +0.6% above today's low and -0.4% off the high.

First Trust NYSE Arca Biotechnology ETF(FBT) shares are trading with a volume of 33K, against a daily average of 53.8K.

During the past year, First Trust NYSE Arca Biotechnology ETF(FBT) stock moved between $152.78 at its lowest and $224.94 at its peak.

During the past year, First Trust NYSE Arca Biotechnology ETF(FBT) stock moved between $152.78 at its lowest and $224.94 at its peak.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.